Article ; Online: Arrivée du mépolizumab dans les syndromes hyperéosinophiliques : la position et les propositions du Centre de référence maladies rares des syndromes hyperéosinophiliques.
2023 Volume 44, Issue 4, Page(s) 155–157
Title translation | Use of mepolizumab in hypereosinophilic syndromes: The position and proposals of the national reference center for hypereosinophilic syndromes. |
---|---|
MeSH term(s) | Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Hypereosinophilic Syndrome/drug therapy ; Eosinophils |
Chemical Substances | mepolizumab (90Z2UF0E52) ; Antibodies, Monoclonal, Humanized |
Language | French |
Publishing date | 2023-03-30 |
Publishing country | France |
Document type | Editorial |
ZDB-ID | 604679-4 |
ISSN | 1768-3122 ; 0248-8663 |
ISSN (online) | 1768-3122 |
ISSN | 0248-8663 |
DOI | 10.1016/j.revmed.2023.03.006 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2451: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.